Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Céline Montavon Sartorius"'
Autor:
Céline Montavon Sartorius, Andreas Schoetzau, Henriette Kettelhack, Daniel Fink, Neville F Hacker, André Fedier, Francis Jacob, Viola Heinzelmann-Schwarz
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0195213 (2018)
The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG
Externí odkaz:
https://doaj.org/article/232f9b0bf3844763856f701e77ff312b
Publikováno v:
The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3388f83f880527f27d0f36d908823bd6
https://doi.org/10.1017/9781108582322.043
https://doi.org/10.1017/9781108582322.043
Publikováno v:
The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d6d3066ff2bdf46de59d69638ef2233
https://doi.org/10.1017/9781108582322.042
https://doi.org/10.1017/9781108582322.042
Autor:
Marcus Vetter, Cornelia Leo, Alexander Schreiber, Daniel Koychev, David Thorn, Céline Montavon Sartorius, Catrina Uhlmann Nussbaum, Elena Laura Georgescu Margarint, Ewelina Biskup, Christian Taverna, A. Müller
Background: Trastuzumab and pertuzumab with taxane-based chemotherapy are considered the first-line standard therapy for human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (mBC). Pertuzumab is also a later-line therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c625729a7af55fe76d9af9d2febc9dcf
https://doi.org/10.21203/rs.3.rs-1051053/v1
https://doi.org/10.21203/rs.3.rs-1051053/v1
Autor:
Gillian Mackay, Céline Montavon Sartorius, Andreas Schötzau, Flurina Am Saner, Viola Heinzelmann-Schwarz
Publikováno v:
Cancer Management and Research. 11:3575-3582
Purpose: Inguinofemoral lymphadenectomy (IFLD) is associated with very high morbidity. Fibrin sealant patches are used in various surgical procedures to prevent hematomas and lymphoceles. Here, we report a single-institution experience of fibrin seal
Autor:
Neville F. Hacker, Viola Heinzelmann-Schwarz, Céline Montavon Sartorius, Gillian Mackay, Andreas Schötzau, Daniel Fink, Uzma Mirza
Publikováno v:
Cancer Management and Research
Céline Montavon Sartorius,1 Uzma Mirza,1 Andreas Schötzau,2 Gillian Mackay,1 Daniel Fink,3 Neville F Hacker,4 Viola Heinzelmann-Schwarz1,2 1Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, S
Autor:
Flurina Am, Saner, Andreas, Schötzau, Gillian, Mackay, Viola, Heinzelmann-Schwarz, Céline, Montavon Sartorius
Publikováno v:
Cancer Management and Research
Purpose: Inguinofemoral lymphadenectomy (IFLD) is associated with very high morbidity. Fibrin sealant patches are used in various surgical procedures to prevent hematomas and lymphoceles. Here, we report a single-institution experience of fibrin seal
Autor:
Viola Heinzelmann-Schwarz, Neville F. Hacker, Henriette Kettelhack, Daniel Fink, Andreas Schoetzau, Francis Jacob, André Fedier, Céline Montavon Sartorius
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0195213 (2018)
PLoS ONE
PLoS ONE
The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG